Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gaucher Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03812042
What this trial is testing

Screening of Lysosomal Storage Disorders Diseases in Minority Groups

Who this might be right for
Lysosomal Storage Diseases
Lysosomal and Rare Disorders Research and Treatment Center, Inc. 100,000
Large-scale testing (Phase 3)Study completedNCT02770625
What this trial is testing

Phase III Study of ISU302 in Patients With Type 1 Gaucher Disease

Who this might be right for
Gaucher Disease, Type 1
ISU Abxis Co., Ltd. 8
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Post-approval studies (Phase 4)Study completedNCT04002830
What this trial is testing

A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease

Who this might be right for
Gaucher Disease, Type 3
Ari Zimran 14
Not applicableLooking for participantsNCT00358943
What this trial is testing

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

Who this might be right for
Gaucher DiseaseCerebroside Lipidosis SyndromeGlucocerebrosidase Deficiency Disease+1 more
Genzyme, a Sanofi Company 12,000
Testing effectiveness (Phase 2)UnknownNCT05447494
What this trial is testing

Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease

Who this might be right for
Gaucher Disease, Type 1Gaucher Disease, Type 3
CANbridge (Suzhou) Bio-pharma Co., Ltd. 40
Early research (Phase 1)Study completedNCT01586455
What this trial is testing

Human Placental-Derived Stem Cell Transplantation

Who this might be right for
Mucopolysaccharidosis IMucopolysaccharidosis VIAdrenoleukodystrophy+13 more
New York Medical College 43
Large-scale testing (Phase 3)WithdrawnNCT01161914
What this trial is testing

The Safety and Efficacy Study of ISU302 in Patient With Type I Gaucher Disease

Who this might be right for
Gaucher Disease
ISU Abxis Co., Ltd.
Early research (Phase 1)Study completedNCT00258778
What this trial is testing

Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD)

Who this might be right for
Gaucher Disease
Protalix 6
Large-scale testing (Phase 3)Study completedNCT00712348
What this trial is testing

Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase

Who this might be right for
Gaucher Disease
Pfizer 31
Not applicableLooking for participantsNCT00029965
What this trial is testing

Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders

Who this might be right for
Neurological RegressionMyoclonusCherry Red Spot+1 more
National Human Genome Research Institute (NHGRI) 200
Not applicableStudy completedNCT03625882
What this trial is testing

Survey Study for Velaglucerase Alfa (VPRIV) in Japan

Who this might be right for
Gaucher Disease
Takeda 63
Large-scale testing (Phase 3)Study completedNCT00635427
What this trial is testing

An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease

Who this might be right for
Gaucher Disease, Type 1
Shire 95
Not applicableActive Not RecruitingNCT06488261
What this trial is testing

Long Term Follow-Up for Safety of AVR-RD-02

Who this might be right for
Gaucher Disease
John Bernat 2
Very early researchActive Not RecruitingNCT06528080
What this trial is testing

A Clinical Study for the Treatment of Pediatric and Adolescent Patients With Type 1 Gaucher Disease

Who this might be right for
Gaucher Disease
Shanghai Jiao Tong University School of Medicine 3
Not applicableStudy completedNCT00244582
What this trial is testing

Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease

Who this might be right for
Type 2 Gaucher Disease
National Institute of Neurological Disorders and Stroke (NINDS) 1
Testing effectiveness (Phase 2)UnknownNCT06523517
What this trial is testing

Efficacy and Safety of Eliglustat in Chinese Pediatric Patients With Gaucher Disease Type 1 and Type 3

Who this might be right for
Gaucher Disease
Peking Union Medical College Hospital 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04411654
What this trial is testing

Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)

Who this might be right for
Gaucher Disease, Type 2
Prevail Therapeutics 7
Not applicableUnknownNCT02520934
What this trial is testing

Miglustat on Gaucher Disease Type IIIB

Who this might be right for
Gaucher Disease
National Taiwan University Hospital 19
Not applicableStudy completedNCT05702814
What this trial is testing

A Study Measuring Substances Potentially Indicating Bone Problems in Adults With Type 1 Gaucher Condition

Who this might be right for
Gaucher Disease
Takeda 125
Next Page